Cytokinetics, Incorporated (CYTK)

Healthcare · Biotechnology · NASDAQ

Cytokinetics, Incorporated (CYTK) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $9.40B and a free-cash-flow yield of -6.6%. Over the most recent reported fiscal year, revenue grew 376.6%.

Market cap	$9.40B
Trailing P/E	—
FCF yield	-6.6%
Revenue growth (YoY)	+376.6%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live CYTK data on Nama Insights →

Recent Congressional trades

Cytokinetics, Incorporated trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jul 2, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Nov 18, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Aug 13, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025